Hyro Secures $20M in Funding Using 15-Slide Pitch Deck for Enterprise Conversational AI Startup

Date:

New York-based conversational AI start-up Hyro has secured $20m of funding in a round featuring Macquarie Capital, Liberty Mutual Strategic Ventures, Black Opal Ventures, K20, Hanaco Ventures, Spero Ventures and Mindset Ventures. The plug-and-play firm offers conversational AI tools that aid automated workflows in messaging services such as call centres, SMS, mobile apps and websites, with a particular focus on healthcare. The funds will be used to build out Hyro’s healthcare offerings, improve lead generation and add new partnerships and integrations. The capital brings the start-up’s total raised to $35m.

Hyro is a plug-and-play AI firm that provides natural language tools to help businesses organise and automate workflows in messaging services including call centres, SMS, mobile apps and websites, with a focus on the healthcare sector. CEO Israel Krush has said Hyro uses large language models in its products, enabling it to maintain explainability while deploying the models. The start-up was founded in 2018.

See also  OpenAI Unveils Sora: Hyperrealistic Video Creation from Text

Frequently Asked Questions (FAQs) Related to the Above News

Please note that the FAQs provided on this page are based on the news article published. While we strive to provide accurate and up-to-date information, it is always recommended to consult relevant authorities or professionals before making any decisions or taking action based on the FAQs or the news article.

Share post:

Subscribe

Popular

More like this
Related

Obama’s Techno-Optimism Shifts as Democrats Navigate Changing Tech Landscape

Explore the evolution of tech policy from Obama's optimism to Harris's vision at the Democratic National Convention. What's next for Democrats in tech?

Tech Evolution: From Obama’s Optimism to Harris’s Vision

Explore the evolution of tech policy from Obama's optimism to Harris's vision at the Democratic National Convention. What's next for Democrats in tech?

Tonix Pharmaceuticals TNXP Shares Fall 14.61% After Q2 Earnings Report

Tonix Pharmaceuticals TNXP shares decline 14.61% post-Q2 earnings report. Evaluate investment strategy based on company updates and market dynamics.

The Future of Good Jobs: Why College Degrees are Essential through 2031

Discover the future of good jobs through 2031 and why college degrees are essential. Learn more about job projections and AI's influence.